Our study showed that although SAA alone does not seem to be a good marker of COPD-related inflammation and disease severity, it may be useful in the assessment of patients with COPD when combined with other disease markers, notably with two of the most important COPD prognostic factors, FEV1 and PaO2. The gene discussed is SAA2; the disease is chronic obstructive pulmonary disease.